UA118076C2 - MEDICINAL PRODUCT IN THE FORM OF CONCENTRATE FOR PREPARATION OF THE INFUSION SOLUTION - Google Patents
MEDICINAL PRODUCT IN THE FORM OF CONCENTRATE FOR PREPARATION OF THE INFUSION SOLUTIONInfo
- Publication number
- UA118076C2 UA118076C2 UAA201803422A UAA201803422A UA118076C2 UA 118076 C2 UA118076 C2 UA 118076C2 UA A201803422 A UAA201803422 A UA A201803422A UA A201803422 A UAA201803422 A UA A201803422A UA 118076 C2 UA118076 C2 UA 118076C2
- Authority
- UA
- Ukraine
- Prior art keywords
- concentrate
- preparation
- infusion solution
- medicinal product
- bioflavonoid
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Лікарський засіб у формі концентрату для приготування інфузійного розчину містить діючу речовину на основі біофлавоноїду, допоміжні речовини та воду для ін'єкцій, як біофлавоноїд містить дигідрокверцетин, додатково містить трометамол, а як допоміжні речовини містить полівінілпіролідон з м. м. 8000 або поліетиленоксид 400, або пропіленгліколь 1,2, або їх комбінації.The drug in the form of concentrate for the preparation of infusion solution contains the active substance based on bioflavonoid, excipients and water for injection, as the bioflavonoid contains dihydroquercetin, additionally contains trometamol, and as excipients contains polyvinylpyrrolidone with m. or propylene glycol 1,2, or combinations thereof.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UAA201607155A UA117389C2 (en) | 2016-07-01 | 2016-07-01 | MEDICINAL PRODUCT IN THE FORM OF CONCENTRATE FOR PREPARATION OF THE INFUSION SOLUTION |
Publications (1)
Publication Number | Publication Date |
---|---|
UA118076C2 true UA118076C2 (en) | 2018-11-12 |
Family
ID=63041298
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA201803421A UA118075C2 (en) | 2016-07-01 | 2016-07-01 | MEDICINAL PRODUCT IN THE FORM OF CONCENTRATE FOR PREPARATION OF THE INFUSION SOLUTION |
UAA201803422A UA118076C2 (en) | 2016-07-01 | 2016-07-01 | MEDICINAL PRODUCT IN THE FORM OF CONCENTRATE FOR PREPARATION OF THE INFUSION SOLUTION |
UAA201607155A UA117389C2 (en) | 2016-07-01 | 2016-07-01 | MEDICINAL PRODUCT IN THE FORM OF CONCENTRATE FOR PREPARATION OF THE INFUSION SOLUTION |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA201803421A UA118075C2 (en) | 2016-07-01 | 2016-07-01 | MEDICINAL PRODUCT IN THE FORM OF CONCENTRATE FOR PREPARATION OF THE INFUSION SOLUTION |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA201607155A UA117389C2 (en) | 2016-07-01 | 2016-07-01 | MEDICINAL PRODUCT IN THE FORM OF CONCENTRATE FOR PREPARATION OF THE INFUSION SOLUTION |
Country Status (1)
Country | Link |
---|---|
UA (3) | UA118075C2 (en) |
-
2016
- 2016-07-01 UA UAA201803421A patent/UA118075C2/en unknown
- 2016-07-01 UA UAA201803422A patent/UA118076C2/en unknown
- 2016-07-01 UA UAA201607155A patent/UA117389C2/en unknown
Also Published As
Publication number | Publication date |
---|---|
UA117389C2 (en) | 2018-07-25 |
UA118075C2 (en) | 2018-11-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2021006035A (en) | Stable cannabinoid formulations. | |
CA3030422C (en) | Stabilizing excipients for therapeutic protein formulations | |
EA201591701A1 (en) | COMBINATION OF ANTI-VIRAL DIRECT ACTION AND RIBAVIRIN FOR THE TREATMENT OF PATIENTS WITH HCV | |
BR112018015367A2 (en) | nanofiber oromucosal carriers for therapeutic treatment | |
CY1123366T1 (en) | 8-AMINO-2-OXO-1,3-DIAZA-SPIRO-[4.5]-DECANE DERIVATIVES | |
CY1119532T1 (en) | (S) -PYRILDOL AND THE PHARMACEUTALLY ACCEPTABLE SALTS FOR USE IN MEDICINE | |
BR112015023481A2 (en) | controlled release liposome drug composition | |
MX2016015211A (en) | Topical formulations and uses thereof. | |
ECSP18060820A (en) | DERIVATIVES OF 3- (CARBOXYETHYL) -8-AMINO-2-OXO-1,3-DIAZA-SPIRO- [4.5] - DECANE | |
CY1119522T1 (en) | (R) - PILINDOL AND THE PHARMACEUTICALALLY ACCEPTABLE SALTS FOR USE IN MEDICINE | |
CL2016000543A1 (en) | Use of pidotimod or its stereoisomers and / or physiologically acceptable salts to prepare a medicament useful in the treatment of diseases associated with inflammation, where there is aberrant hyperactivation of the non-canonical nfkb pathway. | |
UA118076C2 (en) | MEDICINAL PRODUCT IN THE FORM OF CONCENTRATE FOR PREPARATION OF THE INFUSION SOLUTION | |
MX2018008196A (en) | Treatment of breast cancer using a combination of a cationic liposomal formulation of taxane, a non-liposomal formulation of taxane and a further active agent. | |
FR3026012B1 (en) | ORAL ADMINISTRATION OF AT LEAST ONE PHARMACEUTICAL AND / OR ANTIGENIC ACTIVE SUBSTANCE | |
UA122333U (en) | THE COMPOSITION OF ANTI-Fungal, Antimicrobial and Keratolytic Drug | |
UA123395U (en) | PHARMACEUTICAL COMPOSITION OF NISTATIN IN THE FORM OF ORAL SUSPENSION | |
UA131944U (en) | DRUG FOR PREVENTION AND TREATMENT OF PROSTATITIS | |
UA106472U (en) | Composition for treating dermatological diseases | |
UA115903U (en) | PHARMACEUTICAL COMPOSITION IN THE FORM OF GEL FOR TREATMENT OF ALLERGIC DISEASES OF THE SKIN | |
WO2016115442A3 (en) | Therapeutic protein formulations | |
UA106471U (en) | Composition for treating dermatological diseases | |
MX2017014471A (en) | Clonidine and/or clonidine derivatives for use in the prevention of skin injury resulting from radiotherapy. | |
UA112611U (en) | METHOD OF INSECTOACARICIDIC TREATMENT OF BIRDS AND POULTRY OBJECTS | |
EA201692163A1 (en) | MEDICINE FOR THE TREATMENT OF PATIENTS WITH TINNITUS | |
UA114828C2 (en) | APPLICATION OF DECAMETOXIN AS A PHARMACEUTICAL ACTIVE SUBSTANCE FOR TREATMENT OF Gastrointestinal and Intestinal Infections Oral |